This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Analysts' Actions: AMD, EXPE, FDX, WAB

Stocks in this article: AMDEXPEFDXTWXWABLNKDLLYLPX

NEW YORK ( TheStreet) -- CHANGE IN RATINGS



Abiomed (ABMD) was downgraded to Hold at TheStreet Ratings.

Advanced Micro Devices (AMD) was downgraded at UBS to Neutral from Buy with a $4 price target. Lower outlook on structural and competitive challenges.

Aeropostale (ARO) upgraded from Neutral to Buy at Bank of America/Merrill Lynch said. $18 price target. Risk/reward is more attractive following the recent selloff.

CGI Group (GIB) was upgraded to Buy at TheStreet Ratings.

Cliffs Natural (CLF) was downgraded at Credit Suisse from Neutral to Underperform. $30 price target. Company is leveraged to the dramatic fall in iron ore prices.

Cornerstone OnDemand (CSOD) was initiated with a Neutral rating, UBS said. $28 price target. High valuation and expectations.

Expedia (EXPE) was downgraded to Hold from Buy at Jefferies. $56 price target. Solid progress as new platform ramps up.

FedEx (FDX) was downgraded from Outperform to Market Perform at Wells Fargo. Estimates also cut, given weakness at Express.

Guess (GES) was downgraded to Hold at TheStreet Ratings.

HSN (HSNI) was downgraded from Buy to Hold at Wunderlich. $50 price target. Valuation call, based on macro growth concerns.

Hartford Financial Services (HIG) was downgraded to Hold by TheStreet Ratings.

Eli Lilly (LLY) was upgraded from Market Perform to Outperform, Bernstein said. $52 price target. Company has a solid late-stage pipeline and there's a better chance that solanezumab is approved for Alzheimer's.

LinkedIn (LNKD) was upgraded to Buy from Hold at Jeffries. $142 price target. Best play in online recruiting.

Louisiana-Pacific (LPX) was downgraded from Hold to Reduce at TD Securities. Valuation call, based on $12.50 price target.

McKesson (MCK) was upgraded from Neutral to Buy at Mizuho. $99 price target. Recent selloff appears overdone.

Qlik Technologies (QLIK) was upgraded from Equal-weight to Overweight at Morgan Stanley said. $28 price target. Recent survey suggests that demand could remain strong for the next two years.

Time Warner (TWX) was upgraded to Buy from Neutral at UBS. $50 price target. Better stability/visibility to EPS.

ViroPharma (VPHM) was initiated with a Buy rating at Deutsche Bank. $37 price target. HAE drug should be the company's main profit growth driver.

Vitamin Shoppe (VSI) was upgraded from Neutral to Buy at Bank of America/Merrill Lynch. $67 price target. Company can sustain healthy growth.

Westinghouse (WAB) was started with an Outperform rating at Credit Suisse. $99 price target. Company has multiple potential growth levers.

Williams-Sonoma (WSM) was upgraded from Hold to Buy at Deutsche Bank. $48 price target. Consistent sales growth is leading to higher margins.

STOCK COMMENTS / EPS CHANGES

Apple (AAPL) target boosted at JP Morgan. Shares of AAPL now seen reaching $770, according to JP Morgan. iPhone and iPad can continue to grow ahead of expectations. Overweight rating.

Amazon (AMZN) numbers raised at Jefferies. Shares of AMZN now seen reaching $300, Jefferies said. Estimates also raised on superior growth. Buy rating.

Campbell Soup (CPB) numbers raised at UBS. Shares of CPB now seen reaching $36, UBS said. Estimates also raised on higher medium term revenue trends. Neutral rating.

eBay (EBAY) numbers raised at Jefferies. Shares of EBAY now seen reaching $56, Jefferies said. Estimates also raised on turnaround in core biz and upside from PayPal. Buy rating.

FedEx (FDX) numbers cut at UBS. Shares of FDX now seen reaching $110, UBS said. Estimates also lowered on weak Express revenue growth. Buy rating.

Finisar (FNSR) numbers lowered at Citigroup. Shares of FNSR now seen reaching $17, Citigroup said. Estimates also lowered on soft guidance. Buy rating.

Francesca's (FRAN) estimates, target raised at Keybanc. Shares of FRAN now seen reaching $38, according to Keybanc. Estimates also increased, as higher sales are driving margin expansion. Buy rating.

Halliburton (HAL) estimates, target cut at SocGen. HAL estimates were reduced through 2014, Societe Generale said. Company is seeing slower drilling activity in North America. Buy rating and new $50 price target.

J.C. Penny (JCP) estimates lowered at Oppenheimer. JCP estimates lowered through 2013, Oppenheimer said. Turnaround continues to take shape. Outperform rating.

This article was written by a staff member of TheStreet.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,827.75 +12.81 0.07%
S&P 500 2,072.83 +5.80 0.28%
NASDAQ 4,787.3170 +29.0650 0.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs